Showing results (31-40 of 302) with videos related to

Sort By:
Pageof 31
Health Affairs Scholar|April 22, 2026
Cost-effectiveness thresholds used in the United States vs most favored nationsHanxuan Yu, Peter J Neumann, David D Kim, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 20, 2015
The peculiar economics of life-extending therapies: a review of costing methods in health economic evaluations in oncologyNatalia Olchanski, Yue Zhong, Joshua T Cohen, et al.
Applied Health Economics and Health Policy|August 6, 2016
The Cost-Effectiveness of Oral Nutrition Supplementation for Malnourished Older Hospital PatientsYue Zhong, Joshua T Cohen, Scott Goates, et al.
The American Journal of Managed Care|April 17, 2015
Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequencesPei-Jung Lin, David M Kent, Aaron Winn, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 12, 2017
Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction ModelsNatalia Olchanski, Joshua T Cohen, Peter J Neumann, et al.
The Oncologist|May 10, 2020
Balancing Value with Affordability: Cell Immunotherapy for Cancer Treatment in the U.SAshley A Leech, Peter J Neumann, Joshua T Cohen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 15, 2022
Do Cost-Effectiveness Analyses Account for Drug Genericization? A Literature Review and Assessment of ImplicationsPeter J Neumann, Meghan I Podolsky, Anirban Basu, et al.
Applied Health Economics and Health Policy|November 25, 2021
Are Medical Devices Cost-Effective?James D Chambers, Madison C Silver, Flora C Berklein, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 14, 2025
Identifying the Influential Dynamic Inputs in Cost-Effectiveness AnalysesMelanie D Whittington, Joshua T Cohen, Peter J Neumann, et al.
Pharmacoeconomics|July 28, 2016
Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation StudyPei-Jung Lin, Cayla J Saret, Peter J Neumann, et al.
Pageof 31